Rankings
▼
Calendar
XOMAP Q4 2015 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$309M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$48M
Gross Profit
$45M
93.9% margin
Operating Income
$29M
59.6% margin
Net Income
$25M
52.6% margin
EPS (Diluted)
$2.24
Cash Flow
Operating Cash Flow
$29M
Free Cash Flow
$29M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$75M
Total Liabilities
$77M
Stockholders' Equity
-$2M
Cash & Equivalents
$66M
← FY 2015
All Quarters
Q1 2016 →